Bioton S.A. Logo

Bioton S.A.

Develops and manufactures recombinant human insulin for global diabetes care solutions.

BIO | WAR

Overview

Corporate Details

ISIN(s):
PLBIOTN00029
LEI:
259400I5R1L3OPCGII81
Country:
Poland
Address:
Warszawa Starościńska 5, 02-516 Warszawa

Description

Bioton S.A. is an innovative biotechnology company specializing in providing comprehensive solutions for diabetes care. The company's core activities include the research, development, manufacturing, and commercialization of pharmaceutical products, with a primary focus on recombinant human insulin. Bioton manages the entire drug production process, from advanced R&D and the synthesis of active pharmaceutical ingredients to the distribution of finished medicinal products. Recognized as a leader in the Polish market, the company is also one of the top commercial manufacturers of recombinant human insulin globally, operating from its modern production facility near Warsaw.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-28 18:06
Pismo Zarządu
Polish 16.9 KB
2024-03-28 18:06
Pismo Zarządu
Polish 939.5 KB
2024-03-28 18:06
Wybrane dane JSF
Polish 16.9 KB
2024-03-28 18:06
Wybrane dane JSF
Polish 566.6 KB
2024-03-28 17:24
Ujawnienie opóźnionej informacji poufnej dotyczącej statusu prac nad projektami…
Polish 4.4 KB
2024-03-18 20:41
Zmiana terminu publikacji jednostkowego i skonsolidowanego raportu rocznego za …
Polish 757 bytes
2024-01-30 16:07
Terminarz publikacji raportów okresowych BIOTON S.A. w roku 2024 - Content (PL)
Polish 1.5 KB
2023-10-31 19:06
Wybrane dane finansowe skonsolidowane Q3 2023
Polish 196.9 KB
2023-10-31 19:06
Wybrane dane finansowe jednostkowe Q3 2023
Polish 195.9 KB
2023-10-31 19:06
Informacja dodatkowa do Raportu Q3 2023
Polish 594.0 KB
2023-10-31 19:06
Sprawozdanie Finansowe Q3 2023 Grupa Kapitałowa Bioton S.A.
Polish 389.7 KB
2023-08-31 17:24
Wybrane skonsolidowane dane 1H 2023
Polish 583.3 KB
2023-08-31 17:24
Wybrane jednostkowe dane 1H 2023
Polish 582.1 KB
2023-08-31 17:24
Raport biegłego rewidenta 1H 2023 skonsolidowane
Polish 207.5 KB
2023-08-31 17:24
Raport biegłego rewidenta 1H 2023 jednostkowe
Polish 310.8 KB

Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioton S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioton S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.